• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】12218

【品名】5-Methyl-2,4-bis[(trimethylsilyl)methyl]pyrimidine

【CA登记号】

【 分 子 式 】C13H26N2Si2

【 分 子 量 】266.53392

【元素组成】C 58.58% H 9.83% N 10.51% Si 21.07%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(II)

FMAU is prepared by condensation of 3-O-benzoyl-2-fluoro-D-arabinosyl bromide (I) with trimethylsilylated thymine (II) followed by saponification of the protected nucleoside (III).

1 Lopez, C.; Reichman, U.; Fox, J.; Hirota, K.; Watanabe, K.A.; Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem 1979, 22, 1, 21-24.
2 Lopez, C.; Klein, R.S.; Su, T.L.; Fox, J.J.; Watanabe, K.A.; Matsuda, A.; Chun, M.W.; Chun, C.K.; Nucleosides. 123. Synthesis of sntiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-beta-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. J Med Chem 1983, 28, 2, 152-156.
3 Lopez, C.; FMAU. Drugs Fut 1985, 10, 4, 288.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29116 [(2R,3R,4S,5S)-3-(acetoxy)-5-bromo-4-fluorotetrahydro-2-furanyl]methyl benzoate C14H14BrFO5 详情 详情
(II) 12218 5-Methyl-2,4-bis[(trimethylsilyl)methyl]pyrimidine C13H26N2Si2 详情 详情
(III) 29117 [(2R,3R,4S,5R)-3-(acetoxy)-4-fluoro-5-[5-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl benzoate C19H19FN2O7 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XXIII)

Other methods based on the modification of carbohydrates have also been described: 7) Protection of readily available (S)-(+)-gamma-(hydroxymethyl)-gamma-butyrolactone (XIX) with tert-butyldiphenylsilyl chloride gives ether (XX), which is converted to the seleno derivative (XXI) on treatment with lithium hexamethyldisilazide and trimethylchlorosilane in tetrahydrofuran, followed by reaction with phenylselenylbromide. Reduction of (XXI) with diisobutylaluminum hydride in toluene followed by acetylation gives compound (XXII), which is reacted with (XXIII) and trimethylsilyltriflate in dichloroethane to afford stereoselectively compound (XXIV). The latter is finally submitted to elimination and deprotected by successive treatment with hydrogen peroxide in pyridine and tetrabutylammonium fluoride in tetrahydrofuran. 8) A related route involves treatment of (XX) with lithium diisopropylamide in tetrahydrofuran and diphenylsulfide in HMPA to give (XXV), which is reduced and acetylated to yield (XXVI). Compound (XXVI) is treated with (XXIII) in the presence of tin tetrachloride in dichloromethane to afford (XXVII), which is oxidized with sodium periodate and submitted to elimination by treating in toluene-pyridine, to yield compound (XXVIII). Finally, compound (XXVIII) is deprotected with tetrabutylammonium fluoride in tetrahydrofuran. 9) A third procedure begins with the protection of (XIX) as a tert-butoxycarbonyl ester to yield (XXIX), reduction with diisobutylaluminum hydride in tetrahydrofuran to afford (XXX) and elimination after treatment with thionyl chloride in dichloromethane and potassium tert-butoxide in tetrahydrofuran to give (XXXI). Subsequent reaction of compound (XXXI) with thymine (IX) in the presence of hexamethyldisilazane and trimethylsilyl chloride and N-chlorosuccinimide in tetrahydrofuran gives compound (XXXII), which is treated with potassium tert-butoxide in tetrahydrofuran and deprotected with sodium methoxide in methanol.

1 Kim, C.U.; Martin, J.C. (Bristol-Myers Squibb Co.); Processes for preparation of nucleoside derivs. EP 0501511 .
2 Hammoudeh, A.J.; Haft, J.I.; Conte, P.J.; A general method for controlled glycosylation stereochemistry in the synthesis of 2'-deoxyribose nucleosides. Tetrahedron Lett 1990, 31, 2, 1815-8.
3 Robinson, C.; Castaner, J.; Stavudine. Drugs Fut 1994, 19, 10, 925.
4 Babu, J.R.; Beach, J.W.; Ahn, S.K.; Jeong, L.S.; Chu, C.K.; Huang, Huang, H.; Lee, S.J.; A highly stereoselective glycosylation of 2-(phenylselenyl)-2,3-dideoxyribose derivative with thymine: Synthesis of 3'-deoxy-2',3'-didehydrothymidine and 3'-deoxythymidine. J Org Chem 1990, 55, 1418-20.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IX) 12204 5-Methyl-2,4(1H,3H)-pyrimidinedione; Thymine 65-71-4 C5H6N2O2 详情 详情
(XIX) 12008 (5S)-5-(Hydroxymethyl)dihydro-2(3H)-furanone; (S)-(+)-Dihydro-5-(hydroxymethyl)-2(3h)-furanone 32780-06-6 C5H8O3 详情 详情
(XX) 12215 (5S)-5-([[tert-Butyl(diphenyl)silyl]oxy]methyl)dihydro-2(3H)-furanone C21H26O3Si 详情 详情
(XXI) 12216 (3R,5S)-5-([[tert-Butyl(diphenyl)silyl]oxy]methyl)-3-(phenylselanyl)dihydro-2(3H)-furanone C27H30O3SeSi 详情 详情
(XXII) 12217 (3R,5S)-5-([[tert-butyl(diphenyl)silyl]oxy]methyl)-3-(phenylselanyl)tetrahydro-2-furanyl acetate C29H34O4SeSi 详情 详情
(XXIII) 12218 5-Methyl-2,4-bis[(trimethylsilyl)methyl]pyrimidine C13H26N2Si2 详情 详情
(XXIV) 12219 1-[(2R,3R,5S)-5-([[tert-Butyl(diphenyl)silyl]oxy]methyl)-3-(phenylselanyl)tetrahydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione C32H36N2O4SeSi 详情 详情
(XXV) 12220 (3R,5S)-5-([[tert-Butyl(diphenyl)silyl]oxy]methyl)-3-(phenylsulfanyl)dihydro-2(3H)-furanone C27H30O3SSi 详情 详情
(XXVI) 12221 (3R,5S)-5-([[tert-butyl(diphenyl)silyl]oxy]methyl)-3-(phenylsulfanyl)tetrahydro-2-furanyl acetate C29H34O4SSi 详情 详情
(XXVII) 12222 1-[(2R,3R,5S)-5-([[tert-Butyl(diphenyl)silyl]oxy]methyl)-3-(phenylsulfanyl)tetrahydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione C32H36N2O4SSi 详情 详情
(XXVIII) 12223 1-[(2R,5S)-5-([[tert-Butyl(diphenyl)silyl]oxy]methyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione C26H30N2O4Si 详情 详情
(XXIX) 12224 [(2S)-5-oxotetrahydro-2-furanyl]methyl pivalate C10H16O4 详情 详情
(XXX) 12225 [(2S)-5-hydroxytetrahydro-2-furanyl]methyl pivalate C10H18O4 详情 详情
(XXXI) 12226 (2S)-2,3-dihydro-2-furanylmethyl pivalate C10H16O3 详情 详情
(XXXII) 12227 [(2S,4R,5R)-4-chloro-5-[5-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl pivalate C15H21ClN2O5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XXIII)

Finally, the first total synthesis of stavudine has also been described: Starting from epoxide (XXXIII), readily available in four steps from crotonaldehyde, compound (XXXIV) is obtained after reaction with selenophenol and diethylaluminum fluoride in dichloromethane. Reaction of (XXXIV) with hydrochloric acid in methanol-dichloromethane gives (XXXV), which is acetylated to give (XXXVI). Introduction of silylated thymine (XXIII) catalyzed by tert-butyldimethylsilyl triflate in dichloromethane affords compound (XXXVII), which is converted to (XXXVIII) on treatment with m-chloroperbenzoic acid in dichloromethane. Deprotection of (XXXVIII) provides an anomeric mixture of stavudine and its alpha-anomer (XXXIX).

1 Gardiner, J.M.; Jung, M.E.; Synthesis of antiviral nucleosides from crotonaldehyde. Part 3. Total synthesis of didehydrodideoxythymidine (d4T). Tetrahedron Lett 1992, 33, 27, 3841-4.
2 Robinson, C.; Castaner, J.; Stavudine. Drugs Fut 1994, 19, 10, 925.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXIII) 12218 5-Methyl-2,4-bis[(trimethylsilyl)methyl]pyrimidine C13H26N2Si2 详情 详情
(XXXIII) 12228 [3-(2,2-Dimethoxyethyl)-2-oxiranyl]methanol C7H14O4 详情 详情
(XXXIV) 12229 (2R,3S)-5,5-Dimethoxy-3-(phenylselanyl)-1,2-pentanediol C13H20O4Se 详情 详情
(XXXV) 12230 [(2R,3S)-5-Methoxy-3-(phenylselanyl)tetrahydro-2-furanyl]methanol C12H16O3Se 详情 详情
(XXXVI) 12231 [(2R,3S)-5-methoxy-3-(phenylselanyl)tetrahydro-2-furanyl]methyl acetate C14H18O4Se 详情 详情
(XXXVII) 12185 2-Diazo-3-oxo-5-[4-oxo-3-(2-phenoxy-acetamido)-azetidin-2-yl]-pentanoic acid 4-nitro-benzyl ester C23H21N5O8 详情 详情
(XXXVIII) 12233 [(2S)-5-[5-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl]methyl acetate C12H14N2O5 详情 详情
Extended Information